Fundz

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer

PUBLIC · DMACJan 22, 2024

Position

Chief Medical Officer

Company

DiaMedica Therapeutics

Lorianne Masuoka
lmasuoka@diamedica.com
MinneapolisBiotechnologyHealth CareTherapeuticsBiopharma

Description

DiaMedica Therapeutics Inc. appoints Lorianne Masuoka, M.D. as Chief Medical Officer.

Who to call at DiaMedica Therapeutics, and when

A new leader at DiaMedica Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day DiaMedica Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DiaMedica Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DiaMedica Therapeutics

Location

301 CARLSON PARKWAY

Minneapolis, Minnesota, United States

About

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with the focus on acute ischemic stroke and preeclampsia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DiaMedica Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dominic
Likely contact at this company
••••••••@••••••••

See Dominic's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for DiaMedica Therapeutics's next move

Learn about Strategic plan

DiaMedica Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.